22/05/2020 - 11:16

Invex raises $26m for clinical trials

22/05/2020 - 11:16

Bookmark

Save articles for future reference.

Invex Therapeutics has received a $5 million investment from Andrew Forrest’s Tattarang as part of a share placement, with the proceeds to go towards the company’s research into neurological diseases.

To read our articles you will need to either login or subscribe.

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options